Table 3

 Proportion of patients with delayed gastric emptying (GET, t1/2 (minutes) >mean of health asymptomatic controls (2SD)) and augmented symptom response after 600 ml of nutrient challenge (VAS mm >healthy asymptomatic controls (2SD))

Predominant symptomBlood donors with symptoms (n = 48)Patients (n = 40)
Values are number and (%; 95% confidence interval).
IBS, irritable bowel syndrome.
Subjects with abnormal gastric emptying/all subjects
    All subjects25/48 (52.1; 37.2–66.7)18/40 (45.0; 29.3–61.5)
    Dysmotility-type10/16 (33.3; 20.4–48.4)6/9 (15.0; 5.7–29.8)
    Ulcer-type9/14 (18.8; 9.0–32.6)5/13 (12.5; 4.2–26.8)
    IBS6/18 (12.5; 4.7–25.3)7/17 (17.5; 7.3–32.8)
Subjects with augmented symptom response/all subjects
    All subjects14/48 (29.2; 16.9–44.1)16/40 (40.0; 24.9–56.7)
    Dysmotility-type5/16 (10.4; 3.5–23.7)4/9 (10.0; 2.8–23.7)
    Ulcer-type4/14 (8.3; 2.3–20.0)6/13 (15.0; 5.7–29.8)
    IBS5/18 (10.4; 3.5–23.7)6/17 (15.0; 5.7–29.8)